We previously found that deleting the p62 UBA domain, which is responsible for ubiquitin binding and self-oligomerization [82], inhibited cisplatin-induced caspase 8 activation, leading to chemoresistance in ovarian cancer cells. Here, CASP8 is linked to ovarian cancer.